Vincent A Obakachi

4PUBLICATIONS
9CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 08, 2025
Schiff Base Compound of (E)-1-(((4-chloro-2-hydroxyphenyl)imino)methyl)naphthalen-2-ol as CDK2 Inhibitory Agent: Structural Characterization, Density Functional Theory Computational, and In Silico studies.

Segun D Oladipo, Robert C Luckay, Abosede A Badeji

|Sep 22, 2025
Targeting Acute Myeloid Leukemia with 1,2,4-triazolo[4,3-b]pyridazine derivatives: a molecular docking, dynamics, and ADMET approach.

Vincent A Obakachi, Krishna K Govender, Penny P Govender

|Jul 10, 2025
A dynamic scapping workflow for RTK domains: computational modeling of natural products as dual modulators of EGFR and VEGFR signaling in breast cancer.

Vincent A Obakachi, Krishna K Govender, Penny P Govender

|Feb 17, 2025
In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry.

Vincent A Obakachi, Vaderament-A Nchiozem-Ngnitedem, Krishna K Govender

Pageof 1

Frequent Collaborators

3 joint publications

Penny P Govender

2 joint publications

Krishna K Govender

1 joint publications

Vaderament-A Nchiozem-Ngnitedem

1 joint publications

Krishna K Govender